|Bid||0.00 x 1000|
|Ask||0.00 x 1400|
|Day's range||6.66 - 7.59|
|52-week range||4.77 - 23.97|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.00|
At this time, I would like to welcome everyone to the LifeStance Health second quarter 2022 earnings call. Joining me today are Mike Lester, chief executive officer; Danish Qureshi, chief operating officer; and Mike Bruff, chief financial officer.
LifeStance Health (LFST) delivered earnings and revenue surprises of -58.33% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.